cat 3: psma radioligand therapy (prlt) of end-stage prostate cancer patients selected by psma pet/ct
Published 6 years ago • 1K plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:27:12
personalized cancer therapy: using psma radioligand therapy of metastatic prostate cancer
-
32:05
2021: psma and prostate imaging | dr. thomas hope | 2021 moyad scholz mid-year update | pcri
-
0:26
prostate cancer psma pet-ct scan is an imaging test used to detect prostate cancer | rnm center
-
2:00:06
how to use psma-pet/ct in the management of relapsing prostate cancer patients webcast (2023)
-
12:25
psma pet and functional imaging - 2021 prostate cancer patient conference
-
1:40
the significant impact of psma-pet on prostate cancer staging and management
-
14:09
how psma revolutionizes staging for #prostatecancer | #markscholzmd | #pcri
-
1:33
guidelines for using psma pet in the staging of prostate cancer
-
2:56
psma pet ratio predicts response to [177lu]psma radioligand therapy: a multicenter study
-
17:08
psma/pet imaging for prostate cancer
-
2:16
the use of psma pet-ct scans in metastatic prostate cancer
-
2:14
psma pet scan used for prostate cancer – memorial cancer institute
-
10:43
appropriate use of psma pet in clinical practice
-
36:25
psma pet-ct: clinical applications
-
18:26
psma & newly-diagnosed #prostatecancer | markscholzmd #alexscholz #pcri
-
4:09
psma pet-ct scan and treatments for patients with cn1 prostate cancer
-
1:26
remaining questions on psma pet imaging in prostate cancer
-
1:51
psma-targeted therapy in prostate cancer
-
3:24
psma pet-ct in patients with high-risk prostate cancer